Burning Rock Biotech Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 994.88 K | $8.61 M | 0.00% | 92.39% |
| CRCM LP | 11/14/2025 | 221.58 K | $1.92 M | 13.76% | 20.58% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/12/2025 | 34.84 K | $314.28 K | -20.68% | 3.24% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 10/27/2025 | 34.84 K | $301.38 K | -20.68% | 3.24% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 31.72 K | $274.35 K | 0.00% | 2.95% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 29.18 K | $252.39 K | -0.34% | 2.71% |
| PROSPERA FINANCIAL SERVICES INC | 11/06/2025 | 24.76 K | $214.13 K | 100.00% | 2.30% |
| MORGAN STANLEY | 11/14/2025 | 22.27 K | $192.61 K | 22.30% | 2.07% |
| SC CHINA HOLDING LTD | 11/14/2025 | 21.21 K | $215.30 K | 0.00% | 1.97% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 11/10/2025 | 3.00 K | $25.95 K | 100.00% | 0.28% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 900 | $7.79 K | 0.00% | 0.08% |
| SHEN NEIL NANPENG | 11/14/2025 | 885 | $8.98 K | 0.00% | 0.08% |
| UBS GROUP AG | 11/13/2025 | 868 | $7.51 K | 22.43% | 0.08% |
| JPMORGAN CHASE & CO | 11/26/2025 | 64 | $554 | 25.49% | 0.01% |
| BLACKROCK, INC. | 11/12/2025 | 10 | $87 | 0.00% | 0.00% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10/29/2025 | 0 | $0 | -100.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/06/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Burning Rock Biotech Limited institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Burning Rock Biotech Limited. The most heavily invested institutionals were:
Kynam Capital Management, LP: 994,883
CRCM LP: 221,575
Nikko Asset Management Americas, Inc.: 34,842
Sumitomo Mitsui Trust Holdings, Inc.: 34,842
RENAISSANCE TECHNOLOGIES LLC: 31,717
BANK OF AMERICA CORP /DE/: 29,178
131.96% of Burning Rock Biotech Limited stock is owned by institutional investors.
Institutional investors have bought a total of 1.50 M shares in the last 24 months. This purchase volume represents approximately $13.83 M in transactions.